First Manhattan’s Precision BioSciences DTIL Stock Holding History

First Manhattan’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3	Closed	–	–	1714
2022 Q3	$0	Hold	3	–	–	﹤0.01%	1541
2022 Q2	$0	Hold	3	–	–	﹤0.01%	1573
2022 Q1	$0	Hold	3	–	–	﹤0.01%	1613
2021 Q4	$0	Hold	3	–	–	﹤0.01%	1586
2021 Q3	$1K	Hold	3	–	–	﹤0.01%	1544
2021 Q2	$1K	Hold	3	–	–	﹤0.01%	1526
2021 Q1	$1K	Hold	3	–	–	﹤0.01%	1436
2020 Q4	$0	Hold	3	–	–	﹤0.01%	1346
2020 Q3	$0	Hold	3	–	–	﹤0.01%	1350
2020 Q2	$0	Hold	3	–	–	﹤0.01%	1391
2020 Q1	$0	Buy	+3	New	+$785	﹤0.01%	1385

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Manhattan's DTIL Position: Q4 2022 in Review

First Manhattan sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 3 shares.

First Manhattan first reported a position in DTIL in Q1 2020 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

First Manhattan reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
First Manhattan sold 3 Precision BioSciences shares in Q4 2022.
First Manhattan first reported a position in Precision BioSciences in Q1 2020 and held it in 11 quarters.
First Manhattan's Precision BioSciences position peaked at $1K in Q3 2021.
100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.